English
Home > Products > Butyltriphenylphosphonium

China Butyltriphenylphosphonium Factory

We're convinced that with joint initiatives, the business between us will bring us mutual benefits. We can easily guarantee you merchandise good quality and competitive rate for Butyltriphenylphosphonium,CAS NO 1779-51-7,1779-51-7, President of our company, with whole staff, welcomes all buyers to visit our company and inspect. Let us cooperate hand in hand to make a good future.
Butyltriphenylphosphonium, Being the top solutions of our factory, our solutions series have been tested and won us experienced authority certifications. For additional parameters and item list details, be sure to click the button to acquire additional nformation.

Related Products

Hot Products

  • OXANTEL PAMOATE

    OXANTEL PAMOATE

    Product Name:OXANTEL PAMOATE
    Molecular Formula:C49H48N4O8
    Molecular Weight:820.93
    CAS Registry Number:68813-55-8
  • 2,3,4-TRIFLUOROPHENOL

    2,3,4-TRIFLUOROPHENOL

    Product Name:2,3,4-TRIFLUOROPHENOL
    Molecular Formula:C6H3F3O
    Molecular Weight:148.08
    CAS Registry Number:2822-41-5
  • N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine

    N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine

    Product Name:N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine
    Molecular Formula:C12H15FN2O3
    Molecular Weight:254.26
    CAS Registry Number:1289942-66-0
  • (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    Product Name:(3-Chloropyrazin-2-yl)MethanaMine hydrochloride
    Molecular Formula:C5H7Cl2N3
    Molecular Weight:180.03
    CAS Registry Number:939412-86-9
  • rac 7-Methoxy Lasofoxifene

    rac 7-Methoxy Lasofoxifene

    Product Name:rac 7-Methoxy Lasofoxifene
    Molecular Formula:C29H33NO2
    Molecular Weight:427.58
    CAS Registry Number:4796-75-2
  • Lenvatinib

    Lenvatinib

    Product Name:Lenvatinib
    Molecular Formula:C21H19ClN4O4
    Molecular Weight;426.85
    CAS Registry Number;417716-92-8
  • Related Blog
  • Reviews

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept